Literature DB >> 7416253

Brachymesophalangia-V in five samples of children: a descriptive and methodological study.

P H Buschang, R M Malina.   

Abstract

The occurrence of brachmesophalangia-V (BMP-V) in 2,012 individuals from five samples of children of different ethnic backgrounds was determined using two indices. Frequencies of BMP-V were analyzed for three variants: BMP-V alone, BMP-V with clinodactyly, and BMP-V with a cone-shaped epiphysis. The two indices used to identify BMP-V indicated highest relative frequencies among Mexican children, moderate frequencies among children of European ancestry (Pennsylvania White, Canadian, West German), and lower frequencies in Pennsylvania Black children. Index 1, based on the ratio of the width to the length of the fifth mid-phalanx, consistently produced higher frequencies than Index 2, based on the ratio of the length of the fifth to the length of the fourth mid-phalanges. Index 1 was also more selective of BMP-alone, while Index 2 selected primarily BMP-V with clinodactyly and/or cone-shaped epiphyses. The differences between indices were largely due to the fact that Index 1, which basically defines shape, selected both the shortest and/or widest mid-phalanges, while Index 2 related actual length differences. It is suggested that Index 2 provided a more suitable criterion of BMP-V in comparative studies, due to possible population differences in phalangeal shape.

Entities:  

Mesh:

Year:  1980        PMID: 7416253     DOI: 10.1002/ajpa.1330530203

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  2 in total

1.  The expanded spectrum of limb anomalies in the VATER association.

Authors:  S K Fernbach; R B Glass
Journal:  Pediatr Radiol       Date:  1988

2.  Brachydactyly Type A3 Is More Commonly Seen in Children With Short Stature But Does Not Affect Their Height Improvement by Growth Hormone Therapy.

Authors:  Huahong Wu; Yang Li; Hui Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.